WHO ICTRP trial
A prospective, single-arm, single-center clinical study of the preliminary…
ChiCTR2100053515 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100053515 |
|---|---|
| Public title | A prospective, single-arm, single-center clinical study of the preliminary safety and efficacy of thalidomide in the treatment of refractory uremic pruritus |
| Scientific title | A prospective, single-arm, single-center clinical study of the preliminary safety and efficacy of thalidomide in the treatment of refractory uremic pruritus |
| Primary sponsor | Renji Hospital School of Medicine Shanghai Jiao Tong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | urmia pruritus |
| Interventions | Experimental group:Thalidomide |
| Registration date | Nov 23, 2021 |
| Target size | Experimental group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: